Home / Solifenacin / Czechia
CZ ATC G04BD08 · updated 2 Nov 2026
Solifenacin shortage in Czechia
Is there a Solifenacin shortage in Czechia?
Yes. As of 2 Nov 2026, 15 Solifenacin products are reported short in Czechia, the first since 4 Nov 2024. The company estimate for the return is 31 Dec 2026 (latest 1 Aug 2028). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Belgium, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ZABCARE 10MG 10MG TBL FLM 30 | Heaton k.s., Praha | 4 Nov 2024 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ZABCARE 5MG 5MG TBL FLM 30 | Heaton k.s., Praha | 4 Nov 2024 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | FOLINAR 10MG 10MG TBL FLM 60 I | Medochemie Ltd., Limassol | 29 Nov 2024 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 5MG 5MG TBL FLM 60 I | Medochemie Ltd., Limassol | 29 Nov 2024 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 10MG 10MG TBL FLM 100 I | Medochemie Ltd., Limassol | 2 Jul 2025 | 1 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 5MG 5MG TBL FLM 100 I | Medochemie Ltd., Limassol | 2 Jul 2025 | 1 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 10MG 10MG TBL FLM 100 II | Medochemie Ltd., Limassol | 27 Feb 2026 | 1 Oct 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 5MG 5MG TBL FLM 100 II | Medochemie Ltd., Limassol | 27 Feb 2026 | 1 Oct 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | MUSCARISAN 10MG 10MG TBL FLM 100 | Sandoz s.r.o., Praha | 24 Jul 2026 | 18 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | FOLINAR 10MG 10MG TBL FLM 90 I | Medochemie Ltd., Limassol | 1 Nov 2026 | 1 Jul 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 5MG 5MG TBL FLM 90 I | Medochemie Ltd., Limassol | 1 Nov 2026 | 1 Jul 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | SOLIFENACIN VIATRIS 10MG 10MG TBL FLM 100 | VIATRIS LIMITED, Dublin | 1 Nov 2026 | 31 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | ARUSOL 10MG 10MG TBL FLM 100 anticipated | ARDEZ Pharma, spol. s r.o., Kosoř | 1 Dec 2026 | 22 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | FOLINAR 10MG 10MG TBL FLM 90 II anticipated | Medochemie Ltd., Limassol | 8 Jan 2027 | 1 Aug 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | FOLINAR 5MG 5MG TBL FLM 90 II anticipated | Medochemie Ltd., Limassol | 8 Jan 2027 | 1 Aug 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.